Safety and Efficacy of YHD1023 in Erectile Dysfunction
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess the safety and efficacy of oral YHD1023 5g or 10g on
erectile dysfunction to investigate the optimal recommended dosage. Study period is 12 weeks
including 4weeks of follow-up period without treatment. Study patients will fill in the
international index of erectile function questionnaire and life satisfaction questionnaires.